Influenza Human Viral Challenge Studies


hVIVO is the global leader in conducting human viral challenge studies also recently referred to as Controlled Human Infection Models or CHIM. We specialize in respiratory viruses and conduct challenge studies for influenza, Respiratory Syncytial Virus(RSV), and Human Rhinovirus (HRV) hVIVO has conducted 26 influenza human viral challenge studies and inoculated over 1300 subjects with our various influenza strains. hVIVO is the unsurpassed global leader in conducting this type of research since 2001. The current hVIVO H3N2 challenge strain exhibits stronger performance for infection rate and measurable disease than any other influenza challenge strain currently available.